Quinazoline compounds
AssigneeAstraZeneca AB
InventorsLaurent Francois Andre Hennequin, Elaine Sophie Elizabeth Stokes
Life of this patent
Estimating the term…
Loading patent…
AssigneeAstraZeneca AB
InventorsLaurent Francois Andre Hennequin, Elaine Sophie Elizabeth Stokes
Estimating the term…
The invention concerns compounds of the formula (I) wherein ring A is phenyl or 5- or 6-membered heterocyclic ring as defined herein; Z is —O—, —NH— or —S—; m is an integer from 0 to 5 inclusive; R1 is hydrogen, hydroxy, halogeno, nitro, trifluoromethyl, cyano, (C1-3alkyl, C1-3alkoxy, C1-3alkylthio, or —NR5R6 (wherein R5 and R6, which may be the same or different, are hydrogen or C1-3alkyl); R2 is hydrogen, hydroxy, halogeno, C1-3alkyl, C1-3alkoxy, trifluoromethyl, amino or nitro; R3 is hydroxy, halogeno, C1-3alkyl, C1-3alkoxy, C1-3alkanoyloxy, trifluoromethyl, cyano, amino or nitro; provided that when ring A is a 5- or 6-memberecl heterocyclic ring, at least one R3 is either hydroxy or halogeno; X1 is —O—, —CH2—, —S—, —SO—, —SO2—, —NR7—, —NR7CO—, —CONR7, —SO2NR7— or —NR7SO2—, (wherein R7 is hydrogen, C1-3alkyl or C1-3alkoxyC2-3alkyl); and R4 is selected from a number of groups defined herein comprising an C2-5alkylene, C3-5alkenylene or C3-5alkynylene chain wherein each methylene group (other than that of the α-carbon) is optionally substituted by 1 substituent independently selected from hydroxy, halogeno, amino and C1-4alkanoyloxy; provisos are as defined herein. The invention also relates to pharmaceutical compositions comprising a compound of formula (I), to the use of a compound of formula (I) in the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal and to a method for producing an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal in need of such treatment. The compounds are useful in disease states such as cancer, rheumatoid arthritis and psoriasis.
A compound of the formula (I):
A compound according to any one of the preceding claims wherein ring A is phenyl or pyridyl.
A compound according to any one of the preceding claims wherein R3 is hydroxy, halogeno, C1-2alkyl, C1-2alkoxy, trifluoromethyl, cyano, amino or nitro.
A compound according to any one of the preceding claims wherein m is 2 or 3.
A compound according to any one of the preceding claims wherein ring A bearing bearing (R3)m is 2-fluoro-4-chloro-5-hydroxyphenyl, 2-fluoro-4-bromo-5-hydroxyphenyl, 2-fluoro-4-chlorophenyl or 2-fluoro-4-bromophenyl.
A compound according to any one of the preceding claims wherein X1 is —O—, —S—, —NR7CO— or —NR7SO2— (wherein R7 is hydrogen, methyl or ethyl).
A compound selected from
A compound according to any one of the preceding claims in the form of a pharmaceutically acceptable salt.
Dependencies are inferred from the claim text.